Bio-Rad Laboratories, Inc. (BIO) NYSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
1000 Alfred Nobel Drive
Hercules, CA 94547
United States of America (the)
Phone
510 724 7000
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
7700
First IPO Date
February 27, 1980
| Name | Title | Pay | Year Born |
| Norman D. Schwartz | Chairman & Chief Executive Officer | 1.68M | 1950 |
| Rajat Mehta | Executive Vice President of Global Commercial Operations | 649,798 | 1979 |
| Michael Crowley | Executive Vice President of Global Commercial Operations | 649,798 | 1962 |
| Roop K. Lakkaraju | Executive Vice President & Chief Financial Officer | 984,424 | 1971 |
| James J. Barry | Executive Vice President & President of Life Science Group | 1.11M | 1978 |
| Jonathan DiVincenzo | President & Chief Operating Officer | 1.17M | 1966 |
| Erik Molitor | Senior Vice President of Global Technology & Systems | 0 | N/A |
| Matthew Werner | Senior Vice President and Chief Compliance & Privacy Officer | 0 | N/A |
| Ruben Argueta | Vice President of Investor Relations | 0 | N/A |
| Yong Chung | Vice President of Investor Relations | 0 | N/A |
| Courtney C. Enloe | Executive Vice President, General Counsel & Secretary | 0 | 1972 |
| Nanditha R. Yelamanchi | Executive Vice President of Global Human Resources | 0 | N/A |
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.